MedPath

Aminophylline

Approved
Approval ID

9a663ef3-881f-48bd-2689-3713b24545c2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 27, 2023

Manufacturers
FDA

Hospira, Inc.

DUNS: 141588017

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Aminophylline

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-5922
Application NumberANDA087242
Product Classification
M
Marketing Category
C73584
G
Generic Name
Aminophylline
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 29, 2022
FDA Product Classification

INGREDIENTS (3)

ETHYLENEDIAMINEInactive
Code: 60V9STC53F
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
AMINOPHYLLINE DIHYDRATEActive
Quantity: 25 mg in 1 mL
Code: C229N9DX94
Classification: ACTIB

Aminophylline

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-5921
Application NumberANDA087242
Product Classification
M
Marketing Category
C73584
G
Generic Name
Aminophylline
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 29, 2022
FDA Product Classification

INGREDIENTS (3)

ETHYLENEDIAMINEInactive
Code: 60V9STC53F
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
AMINOPHYLLINE DIHYDRATEActive
Quantity: 25 mg in 1 mL
Code: C229N9DX94
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.